Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-12-28

FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth Pharmaceuticals (Pfizer) to modify the existing label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREMARIN VAGINAL (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)